Evaluation of RIDASCREEN® and RIDA®QUICK Helicobacter kits for Helicobacter pylori detection in stools.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 10 04 2020
accepted: 05 06 2020
pubmed: 11 6 2020
medline: 24 4 2021
entrez: 11 6 2020
Statut: ppublish

Résumé

The diagnosis of Helicobacter pylori infection can be made by using noninvasive tests. The detection of bacterial antigens in stool samples is a technique proposed by some suppliers. The objective of this study was to evaluate retrospectively the performances of the commercially available RIDA®QUICK Helicobacter and RIDASCREEN® Helicobacter (R-Biopharm) kits in detecting H. pylori antigens in stool samples. A collection of 132 stools was used in this study: 94 stools obtained from H. pylori-negative patients and 38 stools from H. pylori-positive patients. The performances (sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV)) were evaluated for the RIDA®QUICK Helicobacter and RIDASCREEN® Helicobacter kits in comparison with real-time PCR results performed on gastric biopsies as well as culture. Discordant results, with respect to H. pylori status, were checked on the same day as the test by repeating the procedure. All of the readings concerning the RIDA®QUICK Helicobacter tests were concordant between 3 users, i.e., 94/94 negative tests and 34/38 positive tests. RIDASCREEN® Helicobacter tests were negative for all 94 H. pylori-negative samples and positive for 35/38 positive stools. Reading of the RIDA®QUICK Helicobacter tests was not a problem in routine practice. The RIDA®QUICK Helicobacter and RIDASCREEN® Helicobacter kits show good performances and can be included in the armamentarium of diagnostic tests for H. pylori infection.

Identifiants

pubmed: 32519216
doi: 10.1007/s10096-020-03943-3
pii: 10.1007/s10096-020-03943-3
doi:

Substances chimiques

Antigens, Bacterial 0
Reagent Kits, Diagnostic 0

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1941-1943

Auteurs

Lucie Bénéjat (L)

French National Reference Centre for Campylobacters & Helicobacters, Hôpital Pellegrin, 33076, Bordeaux, France.

Alice Buissonnière (A)

French National Reference Centre for Campylobacters & Helicobacters, Hôpital Pellegrin, 33076, Bordeaux, France.

Astrid Ducournau (A)

French National Reference Centre for Campylobacters & Helicobacters, Hôpital Pellegrin, 33076, Bordeaux, France.

Francis Mégraud (F)

French National Reference Centre for Campylobacters & Helicobacters, Hôpital Pellegrin, 33076, Bordeaux, France.
INSERM, UMR1053 Bordeaux BaRITOn, University of Bordeaux, 33076, Bordeaux, France.

Emilie Bessède (E)

French National Reference Centre for Campylobacters & Helicobacters, Hôpital Pellegrin, 33076, Bordeaux, France.
INSERM, UMR1053 Bordeaux BaRITOn, University of Bordeaux, 33076, Bordeaux, France.

Philippe Lehours (P)

French National Reference Centre for Campylobacters & Helicobacters, Hôpital Pellegrin, 33076, Bordeaux, France. philippe.lehours@u-bordeaux.fr.
INSERM, UMR1053 Bordeaux BaRITOn, University of Bordeaux, 33076, Bordeaux, France. philippe.lehours@u-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH